01 August 2005
Endocannabinoid Signaling in Stress, Medicine and Wellness
Tobias EschMed Sci Monit 2005; 11(8): ED3-5 :: ID: 199607
Abstract
Based on self-care and stress research, it is reasonable to propose thatour bodies contain naturally occurring properties, that is, tools that serve to maintain our health andintegrity for a passable period of time, even in times of stress: These processes, including endocannabinoidautoregulation, might in part determine our well-being and life span. Such properties would also manifestthemselves during times of stress, i.e, stress reduction. Stress potentially triggers endocannabinoidand NO synthesis and release. In fact, endocannabinoids exert stress-reducing functions by their potentialto modulate norepinephrine release, e.g., via constitutive NO activation, therefore suggesting a sympatho-inhibitorymechanism that effectively diminishes sympathetic tone. This stress-reducing and health-promoting potentialcan be detected not only in central but also peripheral pathways, again indicating general or systemicdown-regulation. In this process, signaling molecules such as the endocannabinoids may play a role inconnecting mind and body phenomena, and one could speculate that such evolutionarily old autoregulatorypathways, by using endocannabinoids as one type of their molecular messengers and constitutive NO asa possible converging point, are involved in natural or innate health promotion, including wellness,reward and pleasure. Consequently, endocannabinoid research has now become a focus not only of neurobiologicalbut also medical science: With this interdisciplinary approach, we will gather new insight on these fascinatingmolecules and their healing properties in the coming years ahead.
Keywords: Endocannabinoids - metabolism, Health, Medicine, Stress - metabolism, Cannabinoid Receptor Modulators - metabolism, Endocannabinoids, Health, Medicine, Stress, Physiological - metabolism
Editorial
01 May 2024 : Editorial
Editorial: First Regulatory Approval for Adoptive Cell Therapy with Autologous Tumor-Infiltrating Lymphocytes (TILs) – Lifileucel (Amtagvi)DOI: 10.12659/MSM.944927
Med Sci Monit 2024; 30:e944927
In Press
12 Mar 2024 : Clinical Research
Preoperative Blood Transfusion Requirements for Hemorrhoidal Severe Anemia: A Retrospective Study of 128 Pa...Med Sci Monit In Press; DOI: 10.12659/MSM.943126
12 Mar 2024 : Clinical Research
Tissue Inhibitors of Metalloproteinase 1 (TIMP-1) and 3 (TIMP-3) as New Markers of Acute Kidney Injury Afte...Med Sci Monit In Press; DOI: 10.12659/MSM.943500
12 Mar 2024 : Review article
Optimizing Behçet Uveitis Management: A Review of Personalized Immunosuppressive StrategiesMed Sci Monit In Press; DOI: 10.12659/MSM.943240
12 Mar 2024 : Clinical Research
Metabolomic Alterations in Methotrexate Treatment of Moderate-to-Severe PsoriasisMed Sci Monit In Press; DOI: 10.12659/MSM.943360
Most Viewed Current Articles
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952